Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel antibacterial compound from Banyu

Nov. 15, 1996

Agennix announces patent coverage for lactoferrin

Nov. 15, 1996

Clinical trials with oral and topical BCX-34 in psoriasis

Nov. 15, 1996

New light shed on an old drug: Morphine and its mechanism of action

Nov. 15, 1996

Fujisawa transfers rights to analgesic product to Roxane

Nov. 15, 1996

NDA submitted for breakthrough pain Rx

Nov. 15, 1996

New NK1 antagonists claimed by Takeda

Nov. 15, 1996

Unprecedented efficacy and safety reported for Crinone in gynecological disorders

Nov. 8, 1996

MRC to coordinate large, long-term trial of HRT

Nov. 8, 1996

Third submission for Muse

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...